Expanding coincident signaling by PTEN through its inositol 1,3,4,5,6-pentakisphosphate 3-phosphatase activity

J J Caffrey1, T Darden, M R Wenk

  • 1Laboratory of Signal Transduction, National Institute of Environmental Health Sciences, Research Triangle Park, NC 27709, USA.

FEBS Letters
|June 22, 2001
PubMed

Insights

PTEN, a crucial tumor suppressor, actively dephosphorylates inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P(5)), challenging previous assumptions about its substrates in cancer research.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cancer Research

Background:

  • PTEN is a key tumor suppressor protein involved in human cancers.
  • PTEN functions as a phosphatase, historically recognized for dephosphorylating phosphatidylinositol 3,4,5-trisphosphate (PtdIns(3,4,5)P(3)).
  • Prior research suggested inositol phosphates are not physiologically relevant PTEN substrates.

Purpose of the Study:

  • To investigate PTEN's enzymatic activity towards inositol phosphates.
  • To determine if PTEN can act as an inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P(5)) 3-phosphatase.
  • To explore the physiological relevance of PTEN's interaction with Ins(1,3,4,5,6)P(5) in cellular signaling.

Main Methods:

  • PTEN expression and purification from bacterial and HEK cell systems.
  • Enzymatic assays to determine kinetic parameters (Km) for Ins(1,3,4,5,6)P(5) and PtdIns(3,4,5)P(3).
  • Transient transfection of HEK cells with PTEN to measure in vivo Ins(1,3,4,5,6)P(5) levels.

Main Results:

  • PTEN demonstrated active inositol 1,3,4,5,6-pentakisphosphate (Ins(1,3,4,5,6)P(5)) 3-phosphatase activity.
  • Kinetic analysis revealed competition between Ins(1,3,4,5,6)P(5) (Km=7.1 µM) and PtdIns(3,4,5)P(3) (Km=26 µM) for PTEN.
  • PTEN expression in HEK cells led to a decrease in cellular Ins(1,3,4,5,6)P(5) levels.

Conclusions:

  • PTEN physiologically dephosphorylates Ins(1,3,4,5,6)P(5), a finding that contradicts previous consensus.
  • The results suggest a potential role for PTEN in regulating Ins(1,3,4,5,6)P(5) levels, impacting cell signaling pathways.
  • This study re-evaluates PTEN's substrate specificity and its implications in cancer biology and cellular communication.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...